ŸNSECT GRANTED FIRST APPROVAL OF ITS KIND, TO COMMERCIALISE MEALWORM PROTEINS FOR DOG FOOD IN THE USA
PARIS, Jan. 24, 2024 /PRNewswire/ — Ÿnsect, one of the strongest players in the production of insect-based proteins, has been
Read MorePARIS, Jan. 24, 2024 /PRNewswire/ — Ÿnsect, one of the strongest players in the production of insect-based proteins, has been
Read MoreSINGAPORE, Jan. 24, 2024 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver edge as a service, successfully detected and shielded
Read MoreDUBAI, UAE, Jan. 11, 2024 /PRNewswire/ — Ben Zhou, co-founder and CEO of Bybit, the world’s third largest crypto exchange by
Read MoreAlbumedix Ltd (‘Albumedix’), now part of the life science group Sartorius, announces that Recombumin® is critical to the manufacture of
Read MoreBylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this
Read MoreMAHWAH, N.J. and MUMBAI, India, Nov. 7, 2023 /PRNewswire/ — Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the
Read MoreMONTRÉAL, Oct. 31, 2023 /PRNewswire/ — The Law firm of Faguy & Co. today announces that the Superior Court of
Read MoreSKY-0515 is a small molecule RNA splicing modifier developed through the company’s novel SKYSTAR® platform. SKY-0515’s Phase 1 study will include healthy
Read MorePUNE, India, Oct. 12, 2023 /PRNewswire/ — PhiCommerce, a leading payment technology company based in India, is delighted to announce
Read MoreMONTRÉAL, Sept. 22, 2023 /PRNewswire/ — Law firms Faguy & Co. and Berger Montague (Canada) today announce that the Superior
Read More